Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY was delisted on the 10th of August, 2023.
76 hedge funds and large institutions have $347M invested in Chinook Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 13 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 80 → 76 (-4)
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
24% less capital invested
Capital invested by funds: $456M → $347M (-$108M)
94% less call options, than puts
Call options by funds: $21K | Put options by funds: $348K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$42.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$21.6M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$8.07M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$5.44M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.92M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.35M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.99M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$2.55M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
76
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$6.35M | -41,860 | Closed |
|
|
77
Lord, Abbett & Co
Jersey City,
New Jersey
| – | -$4.99M | -32,881 | Closed |
|
|
78
UBS AM
Chicago,
Illinois
| – | -$2.55M | -16,802 | Closed |
|
79
Citadel Advisors
Miami,
Florida
| – | -$992K | -6,541 | Closed |
|
|
ACH
80
ArrowMark Colorado Holdings
Denver,
Colorado
| – | -$635K | -4,190 | Closed |
|
|
MLICM
81
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$238K | -1,569 | Closed |
|
|
VKH
82
Virtu KCG Holdings
New York
| – | -$232K | -1,532 | Closed |
|
83
RhumbLine Advisers
Boston,
Massachusetts
| – | -$215K | -1,421 | Closed |
|
|
PAM
84
Panagora Asset Management
Boston,
Massachusetts
| – | -$124K | -820 | Closed |
|
|
PCM
85
Prelude Capital Management
New York
| – | -$21K | -140 | Closed |
|
86
Invesco
Atlanta,
Georgia
| – | -$5K | -30 | Closed |
|
|
TRCT
87
Tower Research Capital (TRC)
New York
| – | -$5K | -30 | Closed |
|
|
FNBT
88
FineMark National Bank & Trust
Fort Myers,
Florida
| – | -$1K | -6 | Closed |
|
KDNY Hedge Fund Activity: Q3 2015 in Review
76 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Chinook Therapeutics, Inc. Common Stock (KDNY) for Q3 2015, worth a combined $347M — down 24% from $456M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of KDNY and 10 opened new positions — a net loss of 3 holders — while 26 trimmed existing stakes and 28 added.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $42.5M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $6.92M.
- 76 institutional investors held Chinook Therapeutics, Inc. Common Stock (KDNY) as of Q3 2015, down from 80 in Q2 2015.
- Funds reported $347M of Chinook Therapeutics, Inc. Common Stock stock for Q3 2015, down 24% quarter-over-quarter.
- 10 funds opened new Chinook Therapeutics, Inc. Common Stock positions in Q3 2015 and 13 closed out, a net change of -3 holders.
- The largest Chinook Therapeutics, Inc. Common Stock buyer in Q3 2015 was Janus Henderson Investors US, an estimated $42.5M added.
- The largest Chinook Therapeutics, Inc. Common Stock seller in Q3 2015 was Gilder Gagnon Howe & Co, an estimated $6.92M sold.
Based on aggregated 13F filings for Q3 2015.